Before revision: Separately, a pilot study of Ryoncil on ventilator-assisted Covid-19 patients suffering from Acute Respiratory Distress Syndrome provided sufficient evidence for the FDA to approve a Phase 2/3 placebo-controlled trial on 300 patients.
After revision: Separately, a pilot study of Ryoncil on ventilator-assisted COVID-19 patients with Acute Respiratory Distress Syndrome provided sufficient evidence for the FDA to approve a Phase 2/3 placebo-controlled trial on 300 patients.